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A non-chromogenic, slowly growing Mycobacterium strain was isolated from a maxillary sinus
lavage from a symptomatic patient in Riyadh, Saudi Arabia. It was initially identified as a member of
theMycobacterium tuberculosis complex by a commercial line-probe assay. Its 16S rRNA, hsp65
and rpoB gene and 16S–23S internal transcribed spacer sequences were unique; phylogenetic
analysis based on the 16S rRNA gene sequence groups this organism close to Mycobacterium
szulgai and Mycobacterium malmoense. Its unique biochemical properties and mycolic acid
profile support separate species status. We propose the name Mycobacterium riyadhense sp.
nov. to accommodate this strain. The type strain is NLA000201958T (5CIP 109808T 5DSM
45176T).
A 19-year-old male reported to the otolaryngology
department of the King Faisal Hospital with pain and
swelling of the left side of his face with protrusion of left
eye after blunt trauma. A computed tomography scan of
the sinuses was performed, which revealed a tumour in the
left maxillary sinus. The tumour involved the nasal septum,
extended into the left orbit and infiltrated the medial and
inferior rectus as well as the optic nerve. A chest radiograph
revealed no abnormalities. A lavage of both maxillary
sinuses was performed for diagnosis. Mycobacterial
cultures were performed on Lowenstein–Jensen medium
and yielded an isolate with unusual colony morphology
after 3 weeks of incubation at 36 uC.
The patient was presumed to have bone tuberculosis and
started a 9-month anti-tuberculosis regimen. The patient
improved both clinically and radiologically. He has not
suffered a relapse since. The isolated strain was sent to the
Dutch National Mycobacteria Reference Laboratory
(RIVM, Bilthoven, Netherlands) for identification, as part
of a second-line quality control programme. Identification
of the strain was first attempted using three commercial
line-probe assays, Hain GenoType MTBC and GenoType
AS/CM (Hain Lifescience GmbH) and INNO-LiPA
MYCOBACTERIA v2 (Innogenetics NV), all used accord-
ing to the manufacturers’ instructions.
To obtain identification to the species level, we sequenced
the 16S rRNA gene, 16S–23S internal transcribed spacer
(ITS) and rpoB and hsp65 genes, using previously described
approaches (Springer et al., 1996; Roth et al., 1998; Kim
Abbreviation: ITS, internal transcribed spacer.
The GenBank/EMBL/DDBJ accession numbers for the sequences of
the 16S rRNA, 16S–23S ITS, rpoB, hsp65, esat-6 and cfp-10 genes of
strain NLA000201958T are EU274642, EU274643, EU274644,
EU921671, EU552926 and EU552927.
Phylogenetic trees based on 16S–23S internal transcribed spacer and
hsp65 sequences of selected mycobacterial species are available as
supplementary material with the online version of this paper.
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et al., 1999; Telenti et al., 1993). The DNA sequences
obtained were compared with the RIDOM (Ribosomal
Differentiation of Medical Microorganisms; http://rdna.
ridom.de) and GenBank (National Center for Biotechnology
Information; http://www.ncbi.nlm.nih.gov) databases.
To establish the presence of a region of difference 1 (RD1)-
like element and the DNA sequences of the esat-6 and cfp-
10 genes, we used primers from a previous study (Arend et
al., 2005).
The most commonly investigated biochemical and pheno-
typic features [colony morphology, ability to grow at
temperatures ranging from 24 to 45 uC, niacin accumula-
tion, nitrate reduction, b-glucosidase, Tween 80 hydrolysis,
3 day arylsulfatase, urease, tellurite reduction, 68 uC and
semiquantitative catalase, growth rate, pigmentation,
growth on MacConkey agar and tolerance to NaCl,
thiophene-2-carboxylic hydrazide (TCH), oleate and p-
nitrobenzoic acid and to 10 mg thiacetazone ml21, 1 mg
hydroxylamine ml21 and 500 mg isoniazid ml21, all three
in Middlebrook 7H10 agar] as well as HPLC analysis of
cell-wall mycolic acids were tested by the Regional
Reference Center for Mycobacteria (Careggi Hospital,
Florence, Italy) using standard procedures described
previously (Kent & Kubica, 1985; CDC, 1996).
Drug susceptibility testing was performed using the 25-well
agar-dilution method (van Klingeren et al., 2007). We
included isoniazid, rifampicin, rifabutin, ethambutol,
clarithromycin, ciprofloxacin, cycloserine, prothionamide,
amikacin, clofazimine and streptomycin in the test panel.
Applying the Hain GenoType MTBC assay, a non-specific
reaction was noted with hybridization of the M. tuberculosis
complex band only (banding pattern 1, 2, 3). The InnoLipa
MYCOBACTERIA v2 line-probe assay yielded a
Mycobacterium genus probe reaction, though no species-
specific result. The Hain GenoType CM (Common
Mycobacteria) kit identified the strain as Mycobacterium
tuberculosis complex based on a band 1, 2, 3, 10, 16 pattern.
The supplementary AS kit identified the strain as a non-
specifiedMycobacterium species, with banding pattern 1, 2, 3,
12. Sequencing of the full 23S rRNA gene, the assay’s target,
established its identity as a non-tuberculous mycobacterium
(Table 1). Based on these findings, IS6110 and IS1081 RFLP
were performed to confirm the identity of the strain as M.
tuberculosis (van Soolingen et al., 1993). No IS6110 or IS1081
element copies could be demonstrated (results not shown).
The sequencing results are listed in Table 1; the 16S rRNA
gene, ITS and rpoB and hsp65 gene sequences were all
unique. Sequencing of the full 16S rRNA gene identified
the bacterium as a Mycobacterium szulgai-like species
(Table 1). The 16S rRNA gene sequence was aligned with
those of reference strains of the closest related mycobac-
teria using CLUSTAL_X software (Thompson et al., 1997).
The resulting topology and tree, inferred by neighbour-
joining and visualized using the MEGA software package
(Tamura et al., 2007), were evaluated by bootstrap analyses
based on 1000 resamplings (Fig. 1). The tree was rooted
with Nocardia abscessus ATCC BAA-279T as an outgroup.
Similar multisequence alignments and trees were created
based on the ITS and hsp65 sequences (Supplementary Fig.
S1, available in IJSEM Online).
We were able to amplify an RD1 region, including esat-6
(270 bp) and cfp-10 (251 bp) genes. Results of sequence
comparisons for both genes are recorded in Table 1.
Table 1. Sequence comparisons between strain NLA000201958T and its closest relatives
Where no strain is indicated, multiple highly similar sequences are deposited in GenBank.
Gene/region Most similar sequences
BLAST RIDOM
16S rRNA gene (full) M. malmoense (99%), M. szulgai (99%), M.
bohemicum (98%)
M. szulgai DSM 44166T (99.1%), M. intracellulare
ATCC 35770 (98.4%), M. intracellulare ATCC 35772
(98.4%), M. haemophilum ATCC 29548T (98.4%)
16S–23S ITS (273 bp) M. szulgai (91%), M. kansasii (91%), M.
marinum (91%)
M. kansasii DSM 44162T (92%), M. gastri DSM 43505T
(91%), M. marinum DSM 44344T (90%)
23S rRNA gene (full) M. kansasii (97%), M. avium (97%), M. ulcerans
agy99 (97%)
rpoB (472 bp) M. avium 104 (93%), M. paratuberculosis k10
(93%), M. tuberculosis H37RvT (91%)
hsp65 (421 bp) M. genavense DSM 44424T (95%), M. bohemicum
CIP 105811T (95%), M. malmoense CIP 105775T
(95%)
esat-6 (270 bp) M. kansasii (89%), M. tuberculosis H37RvT (87%),
M. szulgai (85%)
cfp-10 (251 bp) M. tuberculosis H37RvT (88%), M. marinum M
(85%), M. ulcerans (84%)
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On Middlebrook 7H10, Ogawa and Stonebrink media, the
strain produced small, rough, non-pigmented colonies
after 28 days of incubation at 36 uC. After 3 days of
exposure to light at ambient temperature, no pigmentation
was observed. Growth on Middlebrook 7H10 agar was only
observed at 24, 30 and 36 uC. Optimal growth occurred at
36 uC. Colony morphology on Middlebrook 7H10 agar was
similar at all temperatures.
Generally, the biochemical profile of the isolate is unique,
although it shares characteristics with M. szulgai and
Mycobacterium malmoense (Marks et al., 1972). The isolate
was negative for niacin accumulation, heat-stable catalase
(pH 7, 68 uC), b-glucosidase, tellurite reduction, growth
on MacConkey agar and tolerance to p-nitrobenzoic acid,
hydroxylamine and oleic acid, but positive for nitrate
reduction, semiquantitative catalase, Tween 80 hydrolysis,
3 day arylsulfatase and urease activity and tolerance to
TCH, thiacetazone and isoniazid. A comparison with
profiles of M. szulgai and M. malmoense is recorded in
Table 2.
HPLC revealed a pattern characterized by a single, narrow,
late-emerging cluster of peaks. A similar profile is
presented by a limited number of mycobacteria
(Mycobacterium brumae, M. fallax, M. triviale and M.
tuberculosis complex), with none of them fully overlapping
the pattern of the strain characterized here (Fig. 2). We
Fig. 1. Phylogenetic relationships of strain
NLA000201958T (Mycobacterium riyadhense
sp. nov.) and related species of Mycobacter-
ium, based on 16S rRNA gene sequences.
Neighbour-joining tree created and boot-
strapped 1000 times with CLUSTAL_X
(Thompson et al., 1997) and visualized with
MEGA (Tamura et al., 2007). Bootstrap values
are indicated at nodes.
Table 2. Biochemical identification results of strain NLA000201958T and related species
+/2, Strain-dependent reaction.
Test Strain NLA000201958T M. szulgai M. malmoense
Nitrate reduction + + 2
68 uC Catalase 2 + +/2
Catalase .45 mm + + 2
b-Glucosidase 2 +/2 2
Tween 80 hydrolysis + +/2 +
Tellurite reduction 2 +/2 +
3 day Arylsulfatase + + 2
Urease + + 2
Pigmentation Absent Photochromogen Absent
Colony morphology Rough Smooth/rough Smooth
Growth at 25 uC + + +/2
Tolerance to:
p-Nitrobenzoic acid 2 + +
Isoniazid (500 mg ml21)* + +/2 +
Hydroxylamine (1 mg ml21)* 2 2 +/2
*In Middlebrook 7H10 agar.
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used the HPLC mycobacterium library (http://www.myco-
bactoscana.it/English.htm) for this comparison.
Drug susceptibility testing (minimal inhibitory concentra-
tions given in mg ml21) revealed in vitro resistance to
amikacin (10) and p-aminosalicylate (.1), intermediate
susceptibility to isoniazid (1) and susceptibility to rifampi-
cin (0.2), rifabutin (,0.2), ethambutol (5), clarithromycin
(,2), ciprofloxacin (2), cycloserine (20), prothionamide
(,1), clofazimine (,0.5) and streptomycin (5).
Although identification of M. tuberculosis complex is not
the main use of the GenoType CM test, false-positive
results may lead to incorrect diagnoses of tuberculosis and
unwarranted treatment. Aside from the identification as M.
tuberculosis by a line-probe assay, which sparked this study,
both the molecular and HPLC analyses of the novel strain
suggest a phylogenetic relationship withM. tuberculosis; the
presence of an RD1 region strengthens this assumption. Its
identity as a non-tuberculous mycobacterium is easily
proven by sequencing of the 16S rRNA, rpoB, hsp65 or RD1
genes and the absence of IS6110 and IS1081 elements. The
novel strain seems closely related to M. szulgai, based on
16S rRNA gene and ITS sequences (Fig. 1 and
Supplementary Fig. S1a), although it is related more
distantly to M. szulgai based on rpoB and hsp65 sequences
(Table 1 and Supplementary Fig. S1b). Its non-chromo-
genicity, however, is distinct from the photochromogenic
M. szulgai.
Retrospectively, this isolate seems clinically relevant, based
on its isolation from a normally sterile body site and the
symptomatic improvement of the patient after 9 months of
tuberculosis therapy (Griffith et al., 2007). This suggests
that the novel strain was the causative agent of this
patient’s disease.
Both the close phylogenetic relationship with species such
asM. szulgai and Mycobacterium kansasii, which are among
the most pathogenic non-tuberculous mycobacteria
(Griffith et al., 2007; van Ingen et al., 2008), and the
presence of an RD1 region with esat-6 and cfp-10 genes,
which is a virulence factor in M. tuberculosis (Lewis et al.,
2003), add to our view that this strain is a human
pathogen. On the basis of the data presented here, we
describe a novel species to accommodate strain
NLA000201958T, for which we propose the name
Mycobacterium riyadhense sp. nov.
Description of Mycobacterium riyadhense
sp. nov.
Mycobacterium riyadhense (ri.ya.dhen9se. N.L. neut. adj.
riyadhense after Riyadh, capital of the Kingdom of Saudi
Arabia and origin of the patient from whom the type strain
was isolated).
Slowly growing, non-tuberculous mycobacterium that
produces rough, white colonies after 28 days of incubation
at 36 uC; growth is slower at 25 and 30 uC and no growth
occurs at 42 uC. Incorrectly identified as M. tuberculosis
complex by the Hain GenoType CM assay. Negative for
niacin accumulation, heat-stable catalase, b-glucosidase,
tellurite reduction, growth on MacConkey agar and
tolerance to p-nitrobenzoic acid, hydroxylamine and oleic
acid, but positive for nitrate reduction, semiquantitative
catalase, Tween 80 hydrolysis, arylsulfatase and urease
activity and tolerance to TCH, thiacetazone and isoniazid.
Readily identifiable by its unique rRNA gene sequences.
The type strain is NLA000201958T (5CIP 109808T 5DSM
45176T), recovered from maxillary sinus lavage fluid.
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